Showing 17,401 - 17,420 results of 122,478 for search '(( 2 d decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.00s Refine Results
  1. 17401
  2. 17402
  3. 17403
  4. 17404

    Dopamine signals are coupled to the activation of Akt and inactivation of GSK3β in hippocampal neurons (A–D). by Sigeng Chen (248428)

    Published 2008
    “…Quantification of Western blots (n>3) showing the effect of dopamine alone on the phosphorylation of Akt (top) and GSK3β (bottom). C. Treatment with a D2R agonist (Bromocriptine, 5 µM) or a D1R antagonist (SCH23390, 55 µM) for 60 minutes leads to the inactivation of Akt and the activation of GSK3β, whereas treatment with a D2R antagonist (Haloperidol, 10 µM) or a D1R agonist (SKF23383, 33 µM) for 60 minutes leads to the activation of Akt and inactivation of GSK3β. …”
  5. 17405
  6. 17406
  7. 17407
  8. 17408
  9. 17409
  10. 17410
  11. 17411
  12. 17412

    DataSheet5_Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGFβ1/ BMP7 / Gremlin1/ Smad Pathway.xls by Liu Ruiqi (11511985)

    Published 2021
    “…To this aim, we used a model 5/6 nephrectomy and peritoneal fibrosis in rats. …”
  13. 17413

    DataSheet5_Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGFβ1/ BMP7 / Gremlin1/ Smad Pathway.xls by Liu Ruiqi (11511985)

    Published 2021
    “…To this aim, we used a model 5/6 nephrectomy and peritoneal fibrosis in rats. …”
  14. 17414
  15. 17415
  16. 17416
  17. 17417
  18. 17418

    Subgroup analyses of the association between decreases in serum UA levels and poor functional outcome at 3 months. by Kuniyuki Nakamura (13040299)

    Published 2023
    “…<p>The ORs and 95% CIs of poor functional outcome (defined as an mRS score of 3–6 at 3 months) are shown according to UA decrease rate grade (G1 to G4) in each subgroup. The subgroups included (<b>A</b>) age (<75 or ≥75 years), (<b>B</b>) sex (women or men), (<b>C</b>) stroke subtype (non-cardioembolic or cardioembolic), (<b>D</b>) neurological severity (NIHSS <5 or ≥5), (<b>E</b>) CKD (presence or absence), and (<b>F</b>) UA level on admission (<292 or ≥292 μmol/L for women, <351 or ≥351 μmol/L for men). …”
  19. 17419
  20. 17420